Do the Five Combinations of Suicidal Ideation in the FDA 2012 Draft Guidance Document and the C–SSRS Adequately Cover All Suicidal Ideation Combinations in Practice? A Case Study

| October 4, 2014 | 0 Comments

Suicide_Issue_Artby Jennifer M. Giddens and David V. Sheehan, MD, MBA
J. Giddens is Co-founder of the Tampa Center for Research on Suicidality, Tampa, Florida; and Dr. Sheehan is Distinguished University Health Professor Emeritus, University of South Florida College of Medicine, Tampa, Florida.

Innov Clin Neurosci. 2014;11(9–10):172–178

The content you are trying to view is restricted to registered members only.
Membership to Innovations in Clinical Neuroscience is free, so please consider becoming a member today.
Thank you
ICNS Online Editor
Please Login or Register for access.

Tags: , , , , , , , , ,

Category: Case Study, Drug Development, Mood Disorders, Psychiatry, Special Issues, Suicidality, Trial Methodology

Leave a Reply